trending topics
market reports
- 
  MEDICAL JAPAN 2025 OSAKA Returns to Showcase Global Innovations2025-02-17 
- 
  Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!2023-09-01 
- 
  US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight2022-01-21 
- 
  Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines2022-01-21 
- 
  Hong Kong researchers say they develop novel material able to kill COVID-19 virus2022-01-14 
- 
  10 million more Chinese doses on way for Kenya2022-01-14 
- 
  Sino-African ties on track for a brighter future2022-01-07 
- 
  Efforts urged to boost COVID-19 vaccine production capacity in poor countries2022-01-07 
- 
  UAE approves Sinopharm's new protein-based COVID-19 vaccine2022-01-07 
- 
  UAE approves Sinopharm's new protein-based COVID-19 vaccine2022-01-07 
Another 4m doses of Chinese COVID-19 vaccines arrive in Myanmar
2021-09-29
 
YANGON -- Another 4 million doses of China's Sinopharm COVID-19 vaccines purchased by Myanmar arrived at Yangon International Airport on Sunday, according to a release from the Chinese Embassy in Myanmar.
A total of 16.6 million doses of COVID-19 vaccines have been supplied by China to Myanmar so far, of which 3.9 million doses were donated by China, the release said.
Over 3.72 million people have been fully vaccinated nationwide, while over 3.47 million people have received the first jabs of COVID-19 vaccines as of Saturday, the country's Ministry of Health said in a statement on Sunday.
Myanmar reported 1,534 new COVID-19 cases in the past 24 hours, bringing the tally to 458,154 cases in the country on Sunday, the ministry said.
The death toll has increased to 17,527 as of Sunday after 62 more deaths were reported.
 
(Xinhua)
 
               
               
               My Member
My Member Message Center
Message Center 
                 
               
                 
                         
                             
                     
                 
             
                     
                     
                     
                     
                    